← All companies

RGNX

REGENXBIO Inc.

RGNX Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$9.96

-0.16 -1.58%

Key statistics

from XBRL data in SEC filings

Market cap

$515M

Revenue (TTM)

$87.8M

Net income (TTM)

-$290M

EPS (TTM)

$-5.60

P/E ratio

—

Dividend yield

—

Free cash flow

-$126M

Cash

$15.2M

Total assets

$342M

Gross margin

—

52-week range

$5.46 – $16.19

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Other events Jul 20, 2026 8-K Other events Jun 29, 2026 8-K Shareholder vote results; Other events Jun 3, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Results of operations (earnings release); Regulation FD disclosure; Other events May 14, 2026 8-K Entered a material agreement Mar 20, 2026 10-K Fiscal year ended 2025-12-31 Mar 5, 2026 8-K Results of operations (earnings release) Mar 5, 2026 8-K Regulation FD disclosure; Other events Feb 10, 2026 8-K Other events Jan 28, 2026 8-K Results of operations (earnings release) Nov 6, 2025 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Other events Aug 18, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Entered a material agreement; Results of operations (earnings release); Regulation FD disclosure Aug 7, 2025 8-K Shareholder vote results Jun 3, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Regulation FD disclosure May 19, 2025 10-Q Quarter ended 2025-03-31 May 12, 2025 8-K Results of operations (earnings release) May 12, 2025 10-K Fiscal year ended 2024-12-31 Mar 13, 2025 8-K Results of operations (earnings release) Mar 13, 2025 8-K Regulation FD disclosure; Other events Mar 4, 2025 8-K Entered a material agreement; Regulation FD disclosure Jan 14, 2025 8-K Other events Dec 9, 2024 10-Q Quarter ended 2024-09-30 Nov 6, 2024 8-K Results of operations (earnings release) Nov 6, 2024 8-K Director or officer change; Regulation FD disclosure Sep 17, 2024 8-K Director or officer change Aug 6, 2024 10-Q Quarter ended 2024-06-30 Aug 1, 2024 8-K Results of operations (earnings release) Aug 1, 2024 8-K Director or officer change; Regulation FD disclosure Jun 13, 2024 8-K Shareholder vote results Jun 3, 2024 10-Q Quarter ended 2024-03-31 May 8, 2024 8-K Results of operations (earnings release) May 8, 2024 8-K Other events Mar 11, 2024 10-K Fiscal year ended 2023-12-31 Feb 27, 2024 8-K Results of operations (earnings release) Feb 27, 2024 10-Q Quarter ended 2023-09-30 Nov 8, 2023 8-K Results of operations (earnings release) Nov 8, 2023 8-K Other events Sep 1, 2023